Our Technology
Leadership Team
Investor Relations
About Us
Contact Us
Investor relations
Company Announcements
View All
Company Announcements
News
ImmVirX raising $25m led by renowned healthcare VC OneVentures
Company Announcements
June 5, 2023
ImmVirX raising $25m led by renowned healthcare VC OneVentures
Company Announcements
May 19, 2021
by
ImmVirX enters the clinic with next generation oncolytic virus
Company Announcements
April 11, 2023
ImmVirX enters the clinic with next generation oncolytic virus
Company Announcements
May 19, 2021
by
Dr Malcolm McColl
ImmVirX receives $2.81M R&D tax refund for FY22
Company Announcements
November 28, 2022
ImmVirX receives $2.81M R&D tax refund for FY22
Company Announcements
May 19, 2021
by
ImmVirX reports on operations for FY22
Company Announcements
September 26, 2022
ImmVirX reports on operations for FY22
Company Announcements
May 19, 2021
by
ImmVirX receives $858,183 R&D tax refund
Company Announcements
ImmVirX receives $858,183 R&D tax refund
Company Announcements
May 19, 2021
by
ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024
Company Announcements
December 6, 2021
ImmVirX extends Research Services Agreement with University of Newcastle & HMRI through to 2024
Company Announcements
May 19, 2021
by
ImmVirX closes upsized $25m Series A financing
Company Announcements
November 8, 2021
ImmVirX closes upsized $25m Series A financing
Company Announcements
May 19, 2021
by
Resignation of Chairman – Peter Turvey
Company Announcements
August 4, 2021
Resignation of Chairman – Peter Turvey
Company Announcements
May 19, 2021
by
ImmVirX Announces $22 Million Series A Financing
Company Announcements
May 14, 2021
ImmVirX Announces $22 Million Series A Financing
Company Announcements
May 19, 2021
by
Join Our Mailing List
Thank you! Your submission has been received!
Oops! Something went wrong while submitting the form.
Our mission is to improve outcomes for patients with cancers in which immunotherapy treatments have limited effect
About Us
Our Technology
